Source: MarketScreener

MetaboGen: BioGaia : MetaboGen and BioGaia open pilot plant for new bacterial strains

(marketscreener.com) BioGaia is developing probiotic products and expanding its product portfolio with new bacterial strains, developed together with the wholly-owned subsidiary MetaboGen. To take new strains through clinical development and towards eventual launch, the two companies are now opening a pilot plant in Eslöv for fermentation. ...https://www.marketscreener.com/quote/stock/BIOGAIA-AB-PUBL-6491824/news/BioGaia-MetaboGen-and-BioGaia-open-pilot-plant-for-new-bacterial-strains-41641752/?utm_medium=RSS&utm_content=20220829

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Sara Malcus's photo - CEO of MetaboGen

CEO

Sara Malcus

CEO Approval Rating

70/100

Read more